Company Directory / research

DalCor Pharmaceuticals logo

PrivateFor profitresearchMontreal, Canada

DalCor Pharmaceuticals

DalCor is developing precision treatments for cardiovascular disease by genetically targeting patients that will derive clinical benefits

Founded
2015
11 years ago
Staff
11-50
band, as listed
Followers
-
on LinkedIn
Funding
$234M
as listed, currency not stated

Set against six million companies

Size

1-1011-5051-100101-250251-500501-10001k-5k5k-10k10k+

11-50 people: larger than 33% of companies with a size listed

Age

201519002026

11 years old.

Reach

Website ranked #3,751,253 in the world for traffic, about 3k visits a month.

What it does

GeneticsHealth CareMedicalPharmaceutical

Funding, as listed

$234M currency not stated

  • Rounds4
  • LatestSeries d, Sept 2023
  • Investors9, 1 leading

What the source datasets report. We have not watched these rounds ourselves.

FoundersRobert McNeil

Every detail we hold

Everything the source datasets list about DalCor Pharmaceuticals, field by field. Contact details are held but never shown.

The company

Name
DalCor Pharmaceuticals
Type
For profit
Status
Private
Founded
2015
Founders
Robert McNeil
Industry
research
Categories
Genetics, Health Care, Medical, Pharmaceutical

Where

City
Montreal
Country
Canada

Size and reach

Staff band
11-50
Web traffic rank
#3,751,253
Monthly web visits
3,193

Funding, as listed

Total
233,851,699 (currency not stated)
Rounds
4
Latest round
Series d
Latest round date
Sept 2023
Investors
9
Lead investors
1
Listing status
private

About this record

Sources
Crunchbase
Last imported
Sept 2026

Growth, as the source summarises it

DalCor Pharmaceuticals may be growing as it has successfully secured significant funding, with an $80 million investment in its Series D financing round. This influx of capital indicates investor confidence and provides the resources necessary for further development and potential expansion of operations. The repeated mention of this financial milestone across multiple news sources underscores its importance as a growth indicator for the company.

Summaries written by the source dataset, not by us, and not checked.

Companies like it

research in Canada.

See all in the directory →

From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 136,547 companies in Canada and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.